Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain

Documents similaires

• In Response to “Homogeneous ALS Cohorts in Terms of Etiology, Onset Type and Vaccination Status Are Required to Assess the Outcome of Their COVID Infection”
  par: Pilar H. García‐Casanova, et autres
  Publié: (2025)
• Loneliness as neurobehavioral issue in amyotrophic lateral sclerosis
  par: Monica Consonni, et autres
  Publié: (2024)
• Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
  par: Daisuke Ito, et autres
  Publié: (2024)
• Pattern of paresis in amyotrophic lateral sclerosis: A cohort study
  par: Nan Hu, et autres
  Publié: (2024)
• Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis
  par: Raffaele Dubbioso, et autres
  Publié: (2024)